913 related articles for article (PubMed ID: 18923165)
1. Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
Hoshida Y; Villanueva A; Kobayashi M; Peix J; Chiang DY; Camargo A; Gupta S; Moore J; Wrobel MJ; Lerner J; Reich M; Chan JA; Glickman JN; Ikeda K; Hashimoto M; Watanabe G; Daidone MG; Roayaie S; Schwartz M; Thung S; Salvesen HB; Gabriel S; Mazzaferro V; Bruix J; Friedman SL; Kumada H; Llovet JM; Golub TR
N Engl J Med; 2008 Nov; 359(19):1995-2004. PubMed ID: 18923165
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue.
Kim BY; Suh KS; Lee JG; Woo SR; Park IC; Park SH; Han CJ; Kim SB; Jeong SH; Yeom YI; Yang SJ; Kim CM; Cho SJ; Yoo YD; Cho MH; Jang JJ; Choi DW; Lee KH
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S328-38. PubMed ID: 21533656
[TBL] [Abstract][Full Text] [Related]
3. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.
Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581
[TBL] [Abstract][Full Text] [Related]
5. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.
Lim HY; Sohn I; Deng S; Lee J; Jung SH; Mao M; Xu J; Wang K; Shi S; Joh JW; Choi YL; Park CK
Ann Surg Oncol; 2013 Nov; 20(12):3747-53. PubMed ID: 23800896
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Lung Tumor Gene Expression Data Sets.
Faruki H; Mayhew GM; Fan C; Wilkerson MD; Parker S; Kam-Morgan L; Eisenberg M; Horten B; Hayes DN; Perou CM; Lai-Goldman M
Arch Pathol Lab Med; 2016 Jun; 140(6):536-42. PubMed ID: 26430809
[TBL] [Abstract][Full Text] [Related]
7. Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma.
Tsuchiya M; Parker JS; Kono H; Matsuda M; Fujii H; Rusyn I
Mol Cancer; 2010 Apr; 9():74. PubMed ID: 20380719
[TBL] [Abstract][Full Text] [Related]
8. Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma.
Matoba K; Iizuka N; Gondo T; Ishihara T; Yamada-Okabe H; Tamesa T; Takemoto N; Hashimoto K; Sakamoto K; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
Int J Cancer; 2005 Jun; 115(2):231-40. PubMed ID: 15688398
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: a prospective, multicenter study.
Tanaka S; Mogushi K; Yasen M; Ban D; Noguchi N; Irie T; Kudo A; Nakamura N; Tanaka H; Yamamoto M; Kokudo N; Takayama T; Kawasaki S; Sakamoto M; Arii S
Hepatology; 2011 Oct; 54(4):1273-81. PubMed ID: 22006857
[TBL] [Abstract][Full Text] [Related]
10. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.
Iizuka N; Oka M; Yamada-Okabe H; Nishida M; Maeda Y; Mori N; Takao T; Tamesa T; Tangoku A; Tabuchi H; Hamada K; Nakayama H; Ishitsuka H; Miyamoto T; Hirabayashi A; Uchimura S; Hamamoto Y
Lancet; 2003 Mar; 361(9361):923-9. PubMed ID: 12648972
[TBL] [Abstract][Full Text] [Related]
11. Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue.
Kennedy RD; Bylesjo M; Kerr P; Davison T; Black JM; Kay EW; Holt RJ; Proutski V; Ahdesmaki M; Farztdinov V; Goffard N; Hey P; McDyer F; Mulligan K; Mussen J; O'Brien E; Oliver G; Walker SM; Mulligan JM; Wilson C; Winter A; O'Donoghue D; Mulcahy H; O'Sullivan J; Sheahan K; Hyland J; Dhir R; Bathe OF; Winqvist O; Manne U; Shanmugam C; Ramaswamy S; Leon EJ; Smith WI; McDermott U; Wilson RH; Longley D; Marshall J; Cummins R; Sargent DJ; Johnston PG; Harkin DP
J Clin Oncol; 2011 Dec; 29(35):4620-6. PubMed ID: 22067406
[TBL] [Abstract][Full Text] [Related]
12. Whole-genome DASL gene expression profiling of hepatocellular carcinoma sub-populations isolated by laser microdissection on formalin-fixed and paraffin-embedded liver tissue samples.
Cotoi CG; Khorsandi SE; Pleşea IE; Quaglia A
Rom J Morphol Embryol; 2012; 53(4):893-902. PubMed ID: 23303011
[TBL] [Abstract][Full Text] [Related]
13. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
[TBL] [Abstract][Full Text] [Related]
14. Exploration of potential genomic portraits associated with intrahepatic recurrence in human hepatocellular carcinoma.
Kittaka N; Takemasa I; Seno S; Takeda Y; Kobayashi S; Marubashi S; Dono K; Umeshita K; Nagano H; Matsuda H; Monden M; Mori M; Doki Y
Ann Surg Oncol; 2010 Dec; 17(12):3145-54. PubMed ID: 20625842
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of reelin (RELN) gene is associated with high recurrence rate of hepatocellular carcinoma.
Okamura Y; Nomoto S; Kanda M; Hayashi M; Nishikawa Y; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2011 Feb; 18(2):572-9. PubMed ID: 20734148
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma.
Arai E; Ushijima S; Gotoh M; Ojima H; Kosuge T; Hosoda F; Shibata T; Kondo T; Yokoi S; Imoto I; Inazawa J; Hirohashi S; Kanai Y
Int J Cancer; 2009 Dec; 125(12):2854-62. PubMed ID: 19569176
[TBL] [Abstract][Full Text] [Related]
18. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
[TBL] [Abstract][Full Text] [Related]
19. Comparison of archival plasma and formalin-fixed paraffin-embedded tissue for genotyping in hepatocellular carcinoma.
Sjöholm MI; Hoffmann G; Lindgren S; Dillner J; Carlson J
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):251-5. PubMed ID: 15668502
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.
Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY; Gao DM
Clin Cancer Res; 2011 Aug; 17(16):5463-72. PubMed ID: 21712445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
